Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ilaria Cuomo, Georgios D Kotzalidis, Simone de Persis, Daria Piacentino, Filippo Perrini, Emanuela Amici & Sergio De Filippis. (2018) Head-to-head comparison of 1-year aripiprazole long-acting injectable (LAI) versus paliperidone LAI in comorbid psychosis and substance use disorder: impact on clinical status, substance craving, and quality of life. Neuropsychiatric Disease and Treatment 14, pages 1645-1656.
Read now
Read now
Kirsten C. Morley, Jennifer L. Cornish, Alon Faingold, Katie Wood & Paul S. Haber. (2017) Pharmacotherapeutic agents in the treatment of methamphetamine dependence. Expert Opinion on Investigational Drugs 26:5, pages 563-578.
Read now
Read now
Kosuke Okazaki, Manabu Makinodan, Kazuhiko Yamamuro, Tomoyo Takata & Toshifumi Kishimoto. (2016) Blonanserin treatment in patients with methamphetamine-induced psychosis comorbid with intellectual disabilities. Neuropsychiatric Disease and Treatment 12, pages 3195-3198.
Read now
Read now
Articles from other publishers (26)
Claire Herbst, Megan O’Connell, Brittany L. Melton & Karen E. Moeller. (2022) Initiation of Antipsychotic Treatment for Amphetamine Induced Psychosis and Its Impact on Length of Stay. Journal of Pharmacy Practice 36:6, pages 1324-1329.
Crossref
Crossref
Michelle A. Carroll Turpin, Kevin Rowland, Charles Anugwom, Marina Arocha, Anthony Carona, Brianna I. Gonzalez, Geina Iskander, Sarah Snyder, Kennedi Wilson, Alan David Kaye & Elyse M. Cornett. 2023. Substance Use and Addiction Research. Substance Use and Addiction Research
233
263
.
Icro Maremmani, Matteo Pacini & Angelo G. I. MaremmaniIcro Maremmani, Matteo Pacini & Angelo G. I. Maremmani. 2023. Dual Disorder Heroin Addicts. Dual Disorder Heroin Addicts
109
163
.
Ming‐Kung Wu, Kazumi Satogami, Chih‐Sung Liang, Brendon Stubbs, Andre F. Carvalho, Andre R. Brunoni, Kuan‐Pin Su, Yu‐Kang Tu, Yi‐Cheng Wu, Tien‐Yu Chen, Dian‐Jeng Li, Pao‐Yen Lin, Chih‐Wei Hsu, Yen‐Wen Chen, Mein‐Woei Suen, Bing‐Yan Zeng, Shun Takahashi, Ping‐Tao Tseng & Cheng‐Ta Li. (2022) Multiple comparison of different noninvasive brain stimulation and pharmacologic interventions in patients with methamphetamine use disorders: A network meta‐analysis of randomized controlled trials. Psychiatry and Clinical Neurosciences 76:12, pages 633-643.
Crossref
Crossref
Kathrine Louise Jensen, Søren Brøgger Jensen & Kenneth Lindegaard Madsen. (2022) A mechanistic overview of approaches for the treatment of psychostimulant dependence. Frontiers in Pharmacology 13.
Crossref
Crossref
Manit Srisurapanont, Surinporn Likhitsathian, Sirijit Suttajit, Narong Maneeton, Benchalak Maneeton, Awirut Oon‐arom & Chawisa Suradom. (2021) Efficacy and dropout rates of antipsychotic medications for methamphetamine psychosis: A systematic review and network meta-analysis. Drug and Alcohol Dependence 219, pages 108467.
Crossref
Crossref
I. А. Fedotov, D. Quattrone & D. I. Shustov. (2020) Substance-induced psychosis and schizophrenia: the interaction point. I.P. Pavlov Russian Medical Biological Herald 28:4, pages 593-604.
Crossref
Crossref
Gang Wang, Fan Ding, Marek Cezary Chawarski, Wei Hao, Xuebing Liu, Qijian Deng & Xuan Ouyang. (2020) Randomized Controlled Trial of Paliperidone Extended Release Versus Risperidone for the Treatment of Methamphetamine-Associated Psychosis in Chinese Patients. Frontiers in Psychiatry 11.
Crossref
Crossref
Krista J. Siefried, Liam S. Acheson, Nicholas Lintzeris & Nadine Ezard. (2020) Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review. CNS Drugs 34:4, pages 337-365.
Crossref
Crossref
Dimy Fluyau, Paroma Mitra & Kervens Lorthe. (2019) Antipsychotics for Amphetamine Psychosis. A Systematic Review. Frontiers in Psychiatry 10.
Crossref
Crossref
Shih-Fen Chen & Yu-Chih Shen. (2019) Long-Acting Injectable Aripiprazole for a Schizophrenic Patient Concomitant With Stimulant Use Disorder. Journal of Clinical Psychopharmacology 39:5, pages 508-509.
Crossref
Crossref
Mathew Chiang, Domenico Lombardi, Jiang Du, Ursula Makrum, Rangsun Sitthichai, Amy Harrington, Nawras Shukair, Min Zhao & Xiaoduo Fan. (2019) Methamphetamine‐associated psychosis: Clinical presentation, biological basis, and treatment options. Human Psychopharmacology: Clinical and Experimental 34:5.
Crossref
Crossref
Vítor Soares Tardelli, Mariana Pimentel Pádua do Lago, Mariel Mendez, Adam Bisaga & Thiago Marques Fidalgo. (2018) Contingency Management with pharmacologic treatment for Stimulant Use Disorders: A review. Behaviour Research and Therapy 111, pages 57-63.
Crossref
Crossref
António Pedro Delgado Morais, Inês Roque Pita, Carlos Alberto Fontes-Ribeiro & Frederico Costa Pereira. (2018) The neurobiological mechanisms of physical exercise in methamphetamine addiction. CNS Neuroscience & Therapeutics 24:2, pages 85-97.
Crossref
Crossref
Thomas BeresfordJennifer BuchananElizabeth Brie ThummChad EmrickDavid WeitzenkampPatrick J. Ronan. (2017) Late Reduction of Cocaine Cravings in a Randomized, Double-Blind Trial of Aripiprazole vs Perphenazine in Schizophrenia and Comorbid Cocaine Dependence. Journal of Clinical Psychopharmacology 37:6, pages 657-663.
Crossref
Crossref
Matthew L. Banks. (2017) Utility of preclinical drug versus food choice procedures to evaluate candidate medications for methamphetamine use disorder. Annals of the New York Academy of Sciences 1394:1, pages 92-105.
Crossref
Crossref
Panayotis K. Thanos, Ronald Kim, Foteini Delis, Mark J. Rocco, Jacob Cho & Nora D. Volkow. (2017) Effects of chronic methamphetamine on psychomotor and cognitive functions and dopamine signaling in the brain. Behavioural Brain Research 320, pages 282-290.
Crossref
Crossref
Homa Zarrabi, Mohammadrasoul Khalkhali, Azam Hamidi, Reza Ahmadi & Maryam Zavarmousavi. (2016) Clinical features, course and treatment of methamphetamine-induced psychosis in psychiatric inpatients. BMC Psychiatry 16:1.
Crossref
Crossref
Dongming Wang, Wenzhen Li, Yang Xiao, Wulong He, Weiquan Wei, Longyu Yang, Jincong Yu, Fujian Song & Zengzhen Wang. (2016) Tryptophan for the sleeping disorder and mental symptom of new-type drug dependence. Medicine 95:28, pages e4135.
Crossref
Crossref
Gang Wang, Yao Zhang, Sheng Zhang, Huijing Chen, Zaifeng Xu, Richard S. Schottenfeld, Wei Hao & Marek Cezary Chawarski. (2016) Aripiprazole and Risperidone for Treatment of Methamphetamine-Associated Psychosis in Chinese Patients. Journal of Substance Abuse Treatment 62, pages 84-88.
Crossref
Crossref
Matthew L Banks & Bruce E Blough. (2015) Effects of Environmental Manipulations and Treatment with Bupropion and Risperidone on Choice between Methamphetamine and Food in Rhesus Monkeys. Neuropsychopharmacology 40:9, pages 2198-2206.
Crossref
Crossref
John R. Richards, Timothy E. Albertson, Robert W. Derlet, Richard A. Lange, Kent R. Olson & B. Zane Horowitz. (2015) Treatment of toxicity from amphetamines, related derivatives, and analogues: A systematic clinical review. Drug and Alcohol Dependence 150, pages 1-13.
Crossref
Crossref
Karran A. Phillips, David H. Epstein & Kenzie L. Preston. (2014) Psychostimulant addiction treatment. Neuropharmacology 87, pages 150-160.
Crossref
Crossref
Ruohollah Seddigh, Amir-Abbas keshavarz-Akhlaghi & Behnam Shariati. (2014) Treating Methamphetamine-Induced Resistant Psychosis with Clozapine. Case Reports in Psychiatry 2014, pages 1-4.
Crossref
Crossref
Matthew Brensilver, Keith G. Heinzerling & Steven Shoptaw. (2013) Pharmacotherapy of amphetamine-type stimulant dependence: An update. Drug and Alcohol Review, pages n/a-n/a.
Crossref
Crossref
Phillip Oliver Coffin, Glenn‐Milo Santos, Moupali Das, Deirdre M. Santos, Shannon Huffaker, Tim Matheson, James Gasper, Eric Vittinghoff & Grant N. Colfax. (2013) Aripiprazole for the treatment of methamphetamine dependence: a randomized, double‐blind, placebo‐controlled trial. Addiction 108:4, pages 751-761.
Crossref
Crossref